Heartbeat becomes part of Saatchi & Saatchi Wellness

Share this article:
From left: Bill Drummy, Kathy Delaney and JD Cassidy
From left: Bill Drummy, Kathy Delaney and JD Cassidy

Publicis Groupe has announced that Heartbeat Ideas and Heartbeat West will join the network as a Saatchi & Saatchi health entity.

COO of the Publicis Groupe Jean-Yes Naouri stated in the release: “This is a reflection of our continued investment in digital and our faith in the power of health and wellbeing as an increase part of the world's conversation.”

The current New-York based Saatchi & Saatchi group—comprised of Saatchi & Saatchi Wellness and Saatchi & Saatchi Health Communications—will merge, and be known as Saatchi & Saatchi Wellness. Heartbeat and its sister agency will now operate under “Heartbeat Ideas, a member of Saatchi & Saatchi Wellness,” and “Heartbeat West, a member of Saatchi & Saatchi Wellness.”

Bill Drummy, Heartbeat Founder and CEO, commented in the release: “For fifteen years, we've been on a mission to bring a more effective, digitally forward approach to healthcare marketing. By becoming a member of the Publicis Groupe and Saatchi & Saatchi Wellness, we now have the opportunity to be a critical ingredient in an entirely new agency formulation for healthcare clients…”

Drummy remains at the helm at Heartbeat and joins a leadership team of Saatchi & Saatchi Wellness co-managing directors Kathy Delaney and JD Cassidy. Delaney will remain Global Creative Officer. The newly formed leadership team will report to Sam Welch, global group president of PHCG.

Share this article:

Email Newsletters

More in News

In sunny world of LASIK marketers, a dark underbelly

In sunny world of LASIK marketers, a dark ...

Last week, the former FDA branch chief who originally approved LASIK machines asked FDA to reconsider its denial last month of his petition to ban these devices.

BMS Q2 sales slip, Eliquis, Yervoy soar

BMS Q2 sales slip, Eliquis, Yervoy soar

The company attributed part of the Eliquis boost to the BMS-Pfizer DTC and education efforts.

Gilead, Merck HCV marketing battle may be on horizon

Gilead, Merck HCV marketing battle may be on ...

Disclosed in its earnings report yesterday, Gilead may have a card up its sleeve to counter Merck's experimental hep. C combo regimen.